1087 related articles for article (PubMed ID: 30978194)
1. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
[TBL] [Abstract][Full Text] [Related]
3. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
4. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
[TBL] [Abstract][Full Text] [Related]
5. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N
BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850
[TBL] [Abstract][Full Text] [Related]
6. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
7. High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis.
Musisi E; Sessolo A; Kaswabuli S; Zawedde J; Byanyima P; Kasinga S; Sanyu I; Uwimaana E; Walimbwa S; Olore J; Ssengooba W; Sekaggya C; Joloba ML; Worodria W; Huang L; Gillespie SH; Sloan DJ; Sabiiti W
Microbiol Spectr; 2022 Feb; 10(1):e0210021. PubMed ID: 35019686
[TBL] [Abstract][Full Text] [Related]
8. Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections.
Mapamba DA; Sauli E; Lalashowi J; Buza J; John J; Mwaisango Z; Tarmo P; Sabi I; Rachow A; Ntinginya NE; Mtafya B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835127
[TBL] [Abstract][Full Text] [Related]
9. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.
Singh S; Singh A; Prajapati S; Kabra SK; Lodha R; Mukherjee A; Singh V; Hesseling AC; Grewal HM;
BMC Microbiol; 2015 Sep; 15():191. PubMed ID: 26420261
[TBL] [Abstract][Full Text] [Related]
10. Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts.
Jones A; Saini J; Kriel B; Via LE; Cai Y; Allies D; Hanna D; Hermann D; Loxton AG; Walzl G; Diacon AH; Romero K; Higashiyama R; Liu Y; Berg A
BMC Infect Dis; 2022 Apr; 22(1):327. PubMed ID: 35366820
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda.
Sessolo A; Musisi E; Kaswabuli S; Zawedde J; Byanyima P; Sabiiti W; Walimbwa S; Ola J; Sanyu I; Lalitha R; Kamya M; Davis L; Worodria W; Huang L
PLoS One; 2023; 18(4):e0284041. PubMed ID: 37083706
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
Ozkutuk N; Surucüoglu S
Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
[TBL] [Abstract][Full Text] [Related]
13. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
[TBL] [Abstract][Full Text] [Related]
14. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
Tadesse M; Aragaw D; Rigouts L; Abebe G
Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
Peter JG; Theron G; Muchinga TE; Govender U; Dheda K
PLoS One; 2012; 7(7):e39966. PubMed ID: 22815718
[TBL] [Abstract][Full Text] [Related]
17. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
